Intravenous immunoglobulin as clinical immune-modulating therapy
Open Access
- 9 February 2015
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 187 (4), 257-264
- https://doi.org/10.1503/cmaj.130375
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Intravenous immunoglobulin for Guillain-Barré syndromePublished by Wiley ,2012
- Intravenous Immunoglobulin Expands Regulatory T Cells in Autoimmune Rheumatic DiseaseThe Journal of Rheumatology, 2012
- Comparison of IVIg and PLEX in patients with myasthenia gravisNeurology, 2011
- Intravenous immunoglobulin therapy in rheumatic diseasesNature Reviews Rheumatology, 2011
- Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulinJournal of Allergy and Clinical Immunology, 2011
- The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trialsBlood Coagulation & Fibrinolysis, 2010
- Safety of intravenous immunoglobulin treatmentExpert Opinion on Drug Safety, 2010
- Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single‐blinded cross‐over trialEuropean Journal of Neurology, 2009
- INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1985
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982